Hi-Tech Pharmacal Co.

Washington, DC :(May-29-07) Medpointe Pharmaceuticals filed patent infringement charges against drug developer Hi-Tech Pharmacal Co., alleging that the company was distributing a generic version of a cold medication made by Medpointe Pharmaceuticals. Medpointe brought the lawsuit against Hi-Tech after it launched a generic version of Tussi-12, which treats cold and allergy symptoms. Under the settlement agreement, Medpointe will give Hi-Tech rights to its Vosol medications, which are used to treat ear infections. In a settlement reached, Hi-Tech Pharmacal agreed to stop distributing the cold medication made by Medpointe Pharmaceuticals and will pay the company $2.5 million to settle charges of patent infringement. William Peters, Chief Financial Officer for Hi -Tech, stated that the company will likely market the medications as generics rather than under the original brand name. [FORBES: COLD MED PATENT]

Legal Help

If you have a similar problem and would like to be contacted by a lawyer at no cost or obligation, please click the link below.
Published on May-30-07